期刊
JOURNAL OF IMMUNOLOGY
卷 195, 期 1, 页码 277-288出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1402830
关键词
-
类别
资金
- Medical Research Council UK Project [G0800207]
- Arthritis Research UK Programme Grant [19614]
- MRC [MR/K00414X/1, G0800207] Funding Source: UKRI
- Medical Research Council [MR/K00414X/1, G0800207] Funding Source: researchfish
- Versus Arthritis [19614] Funding Source: researchfish
Dual-specificity phosphatase (DUSP) 1 dephosphorylates and inactivates members of the MAPK superfamily, in particular, JNKs, p38 alpha, and p38 beta MAPKs. It functions as an essential negative regulator of innate immune responses, hence disruption of the Dusp1 gene renders mice extremely sensitive to a wide variety of experimental inflammatory challenges. The principal mechanisms behind the overexpression of inflammatory mediators by Dusp1(-/-) cells are not known. In this study, we use a genetic approach to identify an important mechanism of action of DUSP1, involving the modulation of the activity of the mRNA-destabilizing protein tristetraprolin. This mechanism is key to the control of essential early mediators of inflammation, TNF, CXCL1, and CXCL2, as well as the anti-inflammatory cytokine IL-10. The same mechanism also contributes to the regulation of a large number of transcripts induced by treatment of macrophages with LPS. These findings demonstrate that modulation of the phosphorylation status of tristetraprolin is an important physiological mechanism by which innate immune responses can be controlled.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据